Get the Stockscreener App
10.60
5.32%
0.535
Pre-market:
10.64
0.045
+0.42%
Verastem Inc stock is traded at $10.60, with a volume of 1.44M.
It is up +5.32% in the last 24 hours and up +33.94% over the past month.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
See More
Previous Close:
$10.06
Open:
$9.99
24h Volume:
1.44M
Relative Volume:
0.62
Market Cap:
$798.01M
Revenue:
$3.64M
Net Income/Loss:
$-87.37M
P/E Ratio:
-2.5779
EPS:
-4.11
Net Cash Flow:
$-86.46M
1W Performance:
-0.33%
1M Performance:
+33.94%
6M Performance:
+71.72%
1Y Performance:
+92.99%
1-Day Range:
$9.97
$10.63
1-Week Range:
$9.66
$10.79
52-Week Range:
$3.455
$11.24
Verastem Inc Stock (VSTM) Company Profile
Name
Verastem Inc
Sector
Industry
Phone
(781) 292-4200
Address
117 KENDRICK STREET, NEEDHAM, MA
Compare VSTM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VSTM
Verastem Inc
|
10.60 | 757.72M | 3.64M | -87.37M | -86.46M | -4.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Verastem Inc Stock (VSTM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-16-25 | Resumed | Cantor Fitzgerald | Overweight |
| Apr-10-25 | Initiated | Jefferies | Buy |
| Mar-24-25 | Reiterated | H.C. Wainwright | Buy |
| Dec-31-24 | Reiterated | BTIG Research | Buy |
| Sep-30-24 | Initiated | Guggenheim | Buy |
| Nov-21-23 | Resumed | BTIG Research | Buy |
| Sep-27-23 | Initiated | B. Riley Securities | Buy |
| Jun-15-23 | Upgrade | Mizuho | Neutral → Buy |
| Sep-07-22 | Resumed | Alliance Global Partners | Buy |
| Apr-29-22 | Resumed | Cantor Fitzgerald | Overweight |
| Apr-14-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-09-22 | Initiated | Truist | Buy |
| Jul-01-21 | Initiated | Alliance Global Partners | Buy |
| May-24-21 | Upgrade | BTIG Research | Neutral → Buy |
| Jun-20-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-10-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-13-18 | Initiated | BTIG Research | Buy |
| May-02-18 | Initiated | Seaport Global Securities | Buy |
| Mar-08-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Sep-07-17 | Reiterated | H.C. Wainwright | Buy |
| Apr-13-17 | Initiated | Oppenheimer | Outperform |
| Mar-24-17 | Reiterated | H.C. Wainwright | Buy |
| Sep-29-15 | Downgrade | Cantor Fitzgerald | Buy → Hold |
| Sep-29-15 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-29-15 | Downgrade | Jefferies | Buy → Hold |
| Sep-29-15 | Downgrade | Raymond James | Strong Buy → Outperform |
| Sep-28-15 | Downgrade | Mizuho | Buy → Neutral |
| Sep-28-15 | Downgrade | ROTH Capital | Buy → Neutral |
| Sep-09-15 | Initiated | Raymond James | Strong Buy |
| May-12-15 | Reiterated | UBS | Buy |
| Apr-08-15 | Initiated | H.C. Wainwright | Buy |
| Jan-23-15 | Reiterated | ROTH Capital | Buy |
| Jul-08-14 | Resumed | Oppenheimer | Perform |
| Feb-11-14 | Initiated | Mizuho | Buy |
View All
Verastem Inc Stock (VSTM) Latest News
How supply shortages influence Verastem Inc. (2VSA) stock2025 Price Targets & AI Optimized Trading Strategy Guides - Newser
Why Verastem Inc. stock appeals to dividend seekersTrend Reversal & Safe Investment Capital Preservation Plans - Newser
Insider Sell: Dan Paterson Sells 6,000 Shares of Verastem Inc (V - GuruFocus
Does Verastem Inc. (2VSA) stock trade below intrinsic value2025 Top Gainers & Fast Entry Momentum Alerts - Newser
Verastem (NASDAQ:VSTM) CEO Sells $21,580.00 in Stock - MarketBeat
Verastem Inc (VSTM) President and CEO Dan Paterson Sells 6,000 S - GuruFocus
Verastem (NASDAQ:VSTM) CEO Dan Paterson Sells 2,000 Shares - MarketBeat
Verastem (NASDAQ:VSTM) Director Sells $85,500.00 in Stock - MarketBeat
Aug Selloffs: Is Verastem Inc. stock a defensive play in 20252025 Pullback Review & Entry and Exit Point Strategies - BỘ NỘI VỤ
EBITDA per share of Verastem, Inc. – TRADEGATE:2VSA - TradingView
Verastem Executives Engage in Stock Transactions - TradingView
Dir Bunn Sells 6,250 ($62.5K) Of Verastem Inc [VSTM] - TradingView
[Form 4] Verastem, Inc. Insider Trading Activity - Stock Titan
CEO Paterson Sells 6,000 ($60K) Of Verastem Inc [VSTM] - TradingView
Deep Track Capital, LP Acquires Significant Stake in Verastem Inc - GuruFocus
Verastem Oncology to Present at the 8th Annual Evercore Healthcare Conference - MarketScreener
United StatesMintz Advises On Verastem Oncology’s $103 Million Public Offering - Mondaq
Understanding Momentum Shifts in (VSTM) - news.stocktradersdaily.com
Dir Kauffman Files To Sell 8,550 Of Verastem Inc [VSTM] - TradingView
Is Verastem Inc. (2VSA) stock considered safe havenIPO Watch & Accurate Entry and Exit Point Alerts - newser.com
How interest rate cuts could boost Verastem Inc. stock2025 Trade Ideas & Stock Portfolio Risk Management - newser.com
Balyasny Asset Management L.P. Increases Stake in Verastem Inc. - GuruFocus
Verastem Oncology Prices $90 Million Public Offering - Global Legal Chronicle
Verastem Inc. (VSTM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is it too late to sell Verastem Inc.2025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com
Will Verastem Inc. stock deliver better than expected guidanceJuly 2025 Final Week & Accurate Buy Signal Alerts - newser.com
Institutional scanner results for Verastem Inc.July 2025 Market Mood & Real-Time Chart Pattern Alerts - newser.com
Is Verastem Inc. stock cheap at current valuationPortfolio Return Summary & Daily Entry Point Trade Alerts - newser.com
Is Verastem Inc. stock supported by strong cash flowsTrade Risk Summary & Low Drawdown Trading Strategies - newser.com
Will Verastem Inc. stock remain a Wall Street favorite2025 Bull vs Bear & Stock Portfolio Risk Control - newser.com
Is Verastem Inc. (2VSA) stock undervalued after correction2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - newser.com
Will Verastem Inc. (2VSA) stock outperform energy sector in 2025July 2025 Sentiment & Safe Entry Point Alerts - newser.com
Verastem Inc. stock daily chart insightsPortfolio Performance Report & Accurate Buy Signal Alerts - newser.com
How supply chain issues affect Verastem Inc. stockWeekly Risk Summary & High Accuracy Buy Signal Tips - newser.com
Published on: 2025-11-19 14:42:18 - newser.com
Why analysts maintain buy rating on Verastem Inc. (2VSA) stockJuly 2025 EndofMonth & Real-Time Market Sentiment Alerts - newser.com
Candlestick signals on Verastem Inc. stock todayRisk Management & Daily Profit Maximizing Tips - newser.com
Verastem Inc. stock outlook for YEARWeekly Trend Recap & Stock Portfolio Risk Control - newser.com
Published on: 2025-11-19 01:06:51 - newser.com
What technical signals suggest for Verastem Inc. stock2025 Top Decliners & Free Low Drawdown Momentum Trade Ideas - newser.com
Verastem Inc Stock (VSTM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):